December 13, 2012 / 1:20 PM / 5 years ago

BRIEF-Rigel Pharma, Astrazeneca U.S.-listed shares fall in premarket

1 Min Read

NEW YORK, Dec 13 (Reuters) - Rigel Pharmaceuticals: * Rigel Pharma shares slumped 25.9 percent to $6.25 and U.S.-listed shares of Astrazeneca fell 2.1 percent to $47.88 in premarket after study results of the rheumatoid arthritis drug fostamatinib

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below